Sugammadex Sodium

Basic Information

View in Editor

CAS Number

343306-79-6

Molecular Formula

H2NO

Molecular Weight

32.02 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Surfactants Anionic Surfactants

Polymers and Plastics Thermoplastics Polyolefins

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

SMILES

View in Editor

C(CSCC1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(O2)C(C9O)O)CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])O)O)C(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]

InChI

InChI=1S/H2NO/c1-2/h1H2

InChIKey

YLFIGGHWWPSIEG-UHFFFAOYSA-N

LogP

-0.7094

Topological Polar Surface Area

45.92 Å²

Hydrogen Bond Donor/Acceptor

2 / 2

Complexity

2790

Safety Information

View Safety Information

Hazard Statement

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

H335 May cause respiratory irritation
Specific target organ toxicity, single exposure; Respiratory tract irritation

Synonyms & References

English

6A,6B,6C,6D,6E,6F,6G,6H-Octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,6F,6G-octasulfanyl-gamma-cyclodextrin octasodium salt
ORG-25969
Bridion
Sugammadex
Sugammadex sodium
Org 25969
ERJ6X2MXV7
Sugammadex sodium [USAN:JAN]
Bridion (TN)
Sugammadex sodium (JAN/USAN)
D05940
Octasodium 6,6',6'',6''',6'''',6''''',6'''''',6'''''''-octakis-S-(2-carboxylatoethyl)-6,6',6'',6''',6'''',6''''',6'''''',6'''''''-octathiocyclo-alpha-(1-4)-D-octaglucopyranoside
gamma-Cyclodextrin, 6A,6B,6C,6D,6E,7F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,7F,6G,6H-oct
6A,6B,6C,6D,6E,6F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,6F,6G,6H-octathio-?-Cyclodextrin
sodium salt (1:8)
C13789
C72H104Na8O48S8
SCH-900616
Sugammadex octasodium salt
gamma-Cyclodextrin, 6A,6B,6C,6D,6E,7F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,7F,6G,6H-octathio-, octasodium salt
Sugammadex (sodium)
SUGAMMADEX SODIUM [JAN]
SUGAMMADEX OCTASODIUM SALT [MI]
Sugammadex Sodium [USAN]
UNII-ERJ6X2MXV7
SugammadexSodium
6-perdeoxy-6-per(2-carboxyethyl)thio-gamma-cyclodextrin sodium salt
Sugammadex Sodium
.GAMMA.-CYCLODEXTRIN, 6A,6B,6C,6D,6E,7F,6G,6H-OCTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,7F,6G,6H-OCTATHIO-, OCTASODIUM SALT
SUGAMMADEX SODIUM [WHO-DD]
AMY12422

MDL Number

MFCD09954145

FAQ

What regulatory guidelines apply to Sugammadex Sodium (CAS: 343306-79-6)?

Sugammadex Sodium (CAS: 343306-79-6) falls under regulatory guidelines such as REACH in Europe, FDA in the US, and the GHS classification system. Manufacturers and distributors must comply with specific documentation and reporting requirements to ensure safety and environmental protection.

Are there alternatives to Sugammadex Sodium (CAS: 343306-79-6) in synthesis?

While Sugammadex Sodium is the primary compound used, there are alternative reagents like 4,4'-diaminodiphenylmethane and other diaminodiphenylmethane derivatives that can be used as alternatives in certain syntheses. However, these alternatives may not offer the same efficacy and safety profile as Sugammadex Sodium.

What is the market or research trend for Sugammadex Sodium (CAS: 343306-79-6)?

The market for Sugammadex Sodium is growing due to its effectiveness in reversing neuromuscular blockade. Research trends focus on its safety profile, potential in new therapeutic areas, and development of more efficient synthesis methods. The compound remains a key player in anesthesiology and critical care.

How should waste containing Sugammadex Sodium (CAS: 343306-79-6) be handled?

Waste containing Sugammadex Sodium should be collected in appropriate containers and disposed of through professional waste disposal services. Proper environmental protection measures should be taken, including neutralization of waste if necessary, to prevent environmental contamination. Compliance with local and national regulatory requirements is essential.